Duration of survival in patients with myeloma treated with thalidomide.
Barlogie
Bart
B
Shaughnessy
John D
JD
Crowley
John
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D012074:Remission Induction; D016019:Survival Analysis; D013792:Thalidomide / Q000627:therapeutic use*
D013792:Thalidomide